IVVD
IVVD
NASDAQ · Biotechnology

Invivyd Inc

$0.71
+0.05 (+7.31%)
As of Aug 8, 1:56 AM ET ·
Financial Highlights (FY 2026)
Revenue
95.63M
Net Income
-93,961,108
Gross Margin
93.0%
Profit Margin
-98.3%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 93.0% 59.2% 59.2% 59.2%
Operating Margin -104.0% 3.3% 3.0% 2.9%
Profit Margin -98.3% 2.8% 1.9% 2.0%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 95.63M 178.19M 160.29M 142.80M
Gross Profit 88.92M 105.52M 94.92M 84.56M
Operating Income -99,441,241 5.95M 4.86M 4.16M
Net Income -93,961,108 4.92M 3.11M 2.81M
Gross Margin 93.0% 59.2% 59.2% 59.2%
Operating Margin -104.0% 3.3% 3.0% 2.9%
Profit Margin -98.3% 2.8% 1.9% 2.0%
Rev Growth +11.2% +5.5% +8.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 41.24M 37.88M 36.70M
Total Equity 228.36M 219.75M 214.56M
D/E Ratio 0.18 0.17 0.17
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -98,091,944 6.39M 5.91M 5.38M
Free Cash Flow 2.75M 2.88M 2.77M